Medico Remedies Limited

MEDICO

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202669

    Quarter₹ croreYoY
    Jun 202431-2.1%
    Sept 202439-7.1%
    Dec 202439+32.6%
    Mar 2025410.0%
    Jun 202538+24.2%
    Sept 202553+33.8%
    Dec 202559+48.6%
    Mar 202657+37.5%
    Jun 202669+81.4%
  • ₹ crore

    Jun 20261

    Quarter₹ crore
    Jun 20240.29
    Sept 20240.68
    Dec 20241
    Mar 20250.29
    Jun 20250.66
    Sept 20252
    Dec 20250.68
    Mar 20263
    Jun 20261
  • ₹ crore

    Jun 202671

    Quarter₹ crore
    Jun 202431
    Sept 202440
    Dec 202441
    Mar 202542
    Jun 202539
    Sept 202554
    Dec 202559
    Mar 202660
    Jun 202671
  • Cost structure
  • ₹ crore

    Jun 20262

    Quarter₹ crore
    Jun 20241
    Sept 20241
    Dec 20242
    Mar 20252
    Jun 20252
    Sept 20252
    Dec 20252
    Mar 20262
    Jun 20262
  • ₹ crore

    Jun 202667

    Quarter₹ crore
    Jun 202429
    Sept 202438
    Dec 202437
    Mar 202536
    Jun 202536
    Sept 202551
    Dec 202556
    Mar 202651
    Jun 202667
  • Exceptional items and tax
  • ₹ crore

    Jun 20263

    Quarter₹ crore
    Jun 20242
    Sept 20242
    Dec 20243
    Mar 20256
    Jun 20252
    Sept 20253
    Dec 20254
    Mar 20268
    Jun 20263
  • ₹ crore

    Jun 20260.82

    Quarter₹ crore
    Jun 20240.60
    Sept 20240.58
    Dec 20240.88
    Mar 20251
    Jun 20250.62
    Sept 20250.91
    Dec 20250.96
    Mar 20262
    Jun 20260.82
  • Profit
  • ₹ crore

    Jun 20263

    Quarter₹ croreYoY
    Jun 20242+19.6%
    Sept 20242-36.0%
    Dec 20243+81.2%
    Mar 20254+40.1%
    Jun 20252+15.1%
    Sept 20253+65.3%
    Dec 20253+9.7%
    Mar 20266+34.9%
    Jun 20263+38.5%
  • Per share
  • ₹ per share

    Jun 20260.30

    Quarter₹ per share
    Jun 20240.19
    Sept 20240.19
    Dec 20240.32
    Mar 20250.52
    Jun 20250.22
    Sept 20250.31
    Dec 20250.35
    Mar 20260.71
    Jun 20260.30
  • Leverage
  • Debt to equity

    times

    Jun 20260.00x

    Quartertimes
    Jun 20240.00x
    Sept 20240.00x
    Dec 20240.00x
    Mar 20250.00x
    Jun 20250.00x
    Sept 20250.00x
    Dec 20250.00x
    Mar 20260.00x
    Jun 20260.00x
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
313939413853595769
Revenue YoY-2.1%-7.1%+32.6%0.0%+24.2%+33.8%+48.6%+37.5%+81.4%
0.290.6810.290.6620.6831
314041423954596071
Cost structure
112222222
293837363651565167
Exceptional items and tax
223623483
0.600.580.8810.620.910.9620.82
Profit
223423363
Net profit YoY+19.6%-36.0%+81.2%+40.1%+15.1%+65.3%+9.7%+34.9%+38.5%
Per share
0.190.190.320.520.220.310.350.710.30
Leverage
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.